skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

A Cross-National Examination of Differences in Classification of Lifetime Alcohol Use Disorder Between DSM-IV and DSM-5: Findings from the World Mental Health Survey

Slade, Tim ; Chiu, Wai-Tat ; Glantz, Meyer ; Kessler, Ronald C. ; Lago, Luise ; Sampson, Nancy ; Al-Hamzawi, Ali ; Florescu, Silvia ; Moskalewicz, Jacek ; Murphy, Sam ; Navarro-Mateu, Fernando ; Torres de Galvis, Yolanda ; Viana, Maria Carmen ; Xavier, Miguel ; Degenhardt, Louisa

Alcoholism, clinical and experimental research, 2016-08, Vol.40 (8), p.1728-1736 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
  • Título:
    A Cross-National Examination of Differences in Classification of Lifetime Alcohol Use Disorder Between DSM-IV and DSM-5: Findings from the World Mental Health Survey
  • Autor: Slade, Tim ; Chiu, Wai-Tat ; Glantz, Meyer ; Kessler, Ronald C. ; Lago, Luise ; Sampson, Nancy ; Al-Hamzawi, Ali ; Florescu, Silvia ; Moskalewicz, Jacek ; Murphy, Sam ; Navarro-Mateu, Fernando ; Torres de Galvis, Yolanda ; Viana, Maria Carmen ; Xavier, Miguel ; Degenhardt, Louisa
  • Assuntos: Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alcohol Use Disorder ; Alcohol-Related Disorders - classification ; Alcohol-Related Disorders - diagnosis ; Alcohol-Related Disorders - epidemiology ; Cross-Sectional Studies ; Diagnostic and Statistical Manual of Mental Disorders ; DSM-5 ; DSM-IV ; Female ; Global Health - classification ; Health Surveys - classification ; Health Surveys - standards ; Humans ; Internationality ; Male ; Mental Health - classification ; Middle Aged ; Prevalence ; World Health Organization ; Young Adult
  • É parte de: Alcoholism, clinical and experimental research, 2016-08, Vol.40 (8), p.1728-1736
  • Notas: GlaxoSmithKline
    Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund
    National Institute of Drug Abuse (NIDA)
    Ministry of Health
    Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF)
    Secretary of Health of Medellín
    Pan American Health Organization
    John D. and Catherine T. MacArthur Foundation
    Eli Lilly and Company
    State of São Paulo Research Foundation (FAPESP) Thematic Project Grant - No. 03/00204-3
    Ministry of Public Health
    Ortho-McNeil Pharmaceutical
    National Institute of Mental Health (NIMH) - No. R01 MH070884; No. U01-MH60220
    Eli Lilly Romania SRL
    Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social)
    Health & Social Care Research & Development Division of the Public Health Agency
    Fogarty International Center (FIRCA) - No. R03-TW006481
    Substance Abuse and Mental Health Services Administration (SAMHSA)
    Fundación para la Formación e Investigación Sanitarias (FFIS) of Murcia
    Norwegian Financial Mechanism
    John W. Alden Trust
    NHMRC Principal Research Fellowship - No. 1041472
    Polish Ministry of Health
    Table S1. Prevalence of AUDs according to DSM-IV and DSM-5 definitions in (a) Iraq (N = 4,332), (b) Brazil-São Paulo (N = 5,037), (c) Colombia-Medellin (N = 1,673), (d) Romania (N = 2,357), (e) Australia (N = 8,463), (f) Northern Ireland (N = 1,986), (g) Poland (N = 4,000), (h) Portugal (N = 2,060), and (i) Spain-Murcia (N = 1,459). Table S2. Cross-classification of specific DSM-IV and DSM-5 AUD diagnostic subgroups in (a) Iraq (N = 4,332), (b) Brazil-São Paulo (N = 5,037), (c) Colombia-Medellin (N = 1,673), (d) Romania (N = 2,357), (e) Australia (N = 8,463), (f) Northern Ireland (N = 1,986), (g) Poland (N = 4,000), (h) Portugal (N = 2,060), and (i) Spain-Murcia (N = 1,459).
    Bristol-Myers Squibb
    US Public Health Service - No. R13-MH066849; No. R01-MH069864; No. R01 DA016558
    European Economic Area Mechanism
    Champalimaud Foundation
    istex:D891AD870D6094AA8BCF1F5DA454808AC431696B
    ark:/67375/WNG-XLBP1CMS-V
    the Robert Wood Johnson Foundation (RWJF) - No. 044708
    Gulbenkian Foundation
    Pfizer Foundation
    Australian National Health and Medical Research Council (NHMRC) - No. 1081984
    Foundation for Science and Technology (FCT)
    Center for Excellence on Research in Mental Health (CES University)
    ArticleID:ACER13134
    ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Background The current study sought to examine the diagnostic overlap in DSM‐IV and DSM‐5 alcohol use disorder (AUD) and determine the clinical correlates of changing diagnostic status across the 2 classification systems. Methods DSM‐IV and DSM‐5 definitions of AUD were compared using cross‐national community survey data in 9 low‐, middle‐, and high‐income countries. Participants were 31,367 respondents to surveys in the World Health Organization's World Mental Health Survey Initiative. The Composite International Diagnostic Interview, version 3.0, was used to derive DSM‐IV and DSM‐5 lifetime diagnoses of AUD. Clinical characteristics, also assessed in the surveys, included lifetime DSM‐IV anxiety; mood and drug use disorders; lifetime suicidal ideation, plan, and attempt; general functional impairment; and psychological distress. Results Compared with DSM‐IV AUD (12.3%, SE = 0.3%), the DSM‐5 definition yielded slightly lower prevalence estimates (10.8%, SE = 0.2%). Almost one‐third (n = 802) of all DSM‐IV abuse cases switched to subthreshold according to DSM‐5 and one‐quarter (n = 467) of all DSM‐IV diagnostic orphans switched to mild AUD according to DSM‐5. New cases of DSM‐5 AUD were largely similar to those who maintained their AUD across both classifications. Similarly, new DSM‐5 noncases were similar to those who were subthreshold across both classifications. The exception to this was with regard to the prevalence of any lifetime drug use disorder. Conclusions In this large cross‐national community sample, the prevalence of DSM‐5 lifetime AUD was only slightly lower than the prevalence of DSM‐IV lifetime AUD. Nonetheless, there was considerable diagnostic switching, with a large number of people inconsistently identified across the 2 DSM classifications. Compared with DSM‐IV AUD (12.3%, SE = 0.3%), the DSM‐5 definition yielded slightly lower prevalence estimates (10.8%, SE = 0.2%). Diagnostic switching was common with almost one‐third of all DSM‐IV abuse cases switching to subthreshold in DSM‐5 and one‐quarter of all DSM‐IV diagnostic orphans switching to mild DSM‐5 AUD. Despite this, new cases of DSM‐5 AUD were largely similar to those who maintained their AUD across both classifications. Similarly, new DSM‐5 non‐cases were similar to those who were subthreshold across both classifications.
  • Editor: England: Blackwell Publishing Ltd
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.